People · Operator
Named in public records as an officer, director or promoter · active 2009–2026 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Impliant Inc | — | Biotechnology | Series A | $15.6M | $240.5M | 2009 |
| Nasus Pharma Ltd | — | Biotechnology | Series B | $15.0M | $53.5M | 2026 |
| Bio Blast Pharma Ltd. | — | Pharmaceuticals | Series A | $11.4M | $207.5M | 2014 |
Dalia Megiddo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dalia Megiddo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Udi Gilboa | 2 | 2 |
| David Cohen | 1 | 38 |
| Charles Cohen | 1 | 6 |
| Sharon Shacham | 1 | 4 |
| Colin Foster | 1 | 3 |
| David Silberman | 1 | 2 |
| Dan Teleman | 1 | 2 |
| Thomas I. H. Dubin | 1 | 2 |
| Fredric Price | 1 | 2 |
| Ronnie Hershman | 1 | 2 |
| Isaac Israel | 1 | 2 |
| BRIAN CAMERON | 1 | 2 |
| ROBERT COOK | 1 | 2 |
| Zvika Slovin | 1 | 2 |
| Leigh M. Cherry | 1 | 1 |
| Ran Nusbaum | 1 | 1 |
| Isaac I. H. Krymolowski | 1 | 1 |
| Gili M. Cohen | 1 | 1 |
| Marlene Haffner | 1 | 1 |
| Yaron Daniely | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.